Article info
Editors' commentary
Highlights from this issue
Citation
Highlights from this issue
Publication history
- Accepted October 21, 2016
- First published November 15, 2016.
Online issue publication
November 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Bell's palsy syndrome: mimics and chameleons
- CIDP: mimics and chameleons
- Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
- T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
- CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
- Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
- CIDP presenting as recurrent severe back pain without weakness or sensory loss
- Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study
- Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies
- Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy